* Cue Health Inc HLTH.OQ HLTH.O is expected to show a
fall in
quarterly revenue when it reports results on March 13 for the
period ending December 31 2023
* The San Diego California-based company is expected to
report a
88.0% decrease in revenue to $17.681 million from $146.78
million a year ago, according to the mean estimate from 3
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Cue Health Inc is for a
loss
of 44 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cue Health
Inc is
$0.88, above its last closing price of $0.26.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 -0.44 -0.45 -0.43 Beat 4.4
Jun. 30 2023 -0.47 -0.50 -0.55 Missed -10.7
Mar. 31 2023 -0.62 -0.61 -0.62 Missed -2.1
Dec. 31 2022 -0.47 -0.51 -0.21 Beat 58.8
Sep. -0.54 -0.54 -0.45 Beat 17.1
30 2022
Jun. 30 2022 -0.47 -0.46 -0.37 Beat 20
Mar. 31 2022 -0.05 -0.05 0.02 Beat 138.1
Dec. 31 2021 0.10 0.11 0.22 Beat 109.5
This summary was machine generated March 11 at 20:21 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)